Cargando…

Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin

Cardiovascular diseases (CVDs) are the major cause of morbidity/mortality among breast cancer (BC) patients. Observation of the daily practice in eight experienced Polish oncology centers was conducted to find all possible predictors of new cases of heart failure (HF) and overall survival (OS) of me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szmit, Sebastian, Grela-Wojewoda, Aleksandra, Talerczyk, Małgorzata, Kufel-Grabowska, Joanna, Streb, Joanna, Smok-Kalwat, Jolanta, Iżycki, Dariusz, Chmielowska, Ewa, Wilk, Michał, Sosnowska-Pasiarska, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595106/ https://www.ncbi.nlm.nih.gov/pubmed/33116159 http://dx.doi.org/10.1038/s41598-020-75614-4

Ejemplares similares

Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy
por: Grywalska, Ewelina, et al.
Publicado: (2020)

CAR-T Cell Therapy—An Overview of Targets in Gastric Cancer
por: Bębnowska, Dominika, et al.
Publicado: (2020)

Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review
por: Grywalska, Ewelina, et al.
Publicado: (2020)

Toll-like Receptor 2 as a Marker Molecule of Advanced Ovarian Cancer
por: Sobstyl, Małgorzata, et al.
Publicado: (2021)

Expression of CTLA-4 and CD86 Antigens and Epstein-Barr Virus Reactivation in Chronic Lymphocytic Leukemia—Any Link with Known Prognostic Factors?
por: Grywalska, Ewelina, et al.
Publicado: (2022)

Estrogen Receptor Signaling in Breast Cancer
por: Miziak, Paulina, et al.
Publicado: (2023)

Shifting Treatment Paradigms: Improvements in HR-Positive, HER-2- Negative Breast Cancer Care in Poland from a Clinical Perspective
por: Ziobro, Marek, et al.
Publicado: (2023)

The Effect of Vinyasa Yoga Practice on the Well-Being of Breast-Cancer Patients during COVID-19 Pandemic
por: Zok, Agnieszka, et al.
Publicado: (2023)

Analysis of Copper Concentration in Human Serum by Application of Total Reflection X-ray Fluorescence Method
por: Kubala-Kukuś, Aldona, et al.
Publicado: (2014)

The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
por: Smok-Kalwat, Jolanta, et al.
Publicado: (2023)

Cardiovascular Complications of Prostate Cancer Treatment
por: Wilk, Michał, et al.
Publicado: (2020)

Intra-Tumor Heterogeneity Revealed by Mass Spectrometry Imaging Is Associated with the Prognosis of Breast Cancer
por: Gawin, Marta, et al.
Publicado: (2021)

Exploring the Significance of Immune Checkpoints and EBV Reactivation in Antibody Deficiencies with Near-Normal Immunoglobulin Levels or Hyperimmunoglobulinemia
por: Mertowska, Paulina, et al.
Publicado: (2023)

Biomarkers of Trastuzumab-Induced Cardiac Toxicity in HER2- Positive Breast Cancer Patient Population
por: Grela-Wojewoda, Aleksandra, et al.
Publicado: (2022)

A Two-Year Follow-Up Cohort Study—Improved Clinical Control over CVD Risk Factors through Weight Loss in Middle-Aged and Older Adults
por: Macek, Pawel, et al.
Publicado: (2020)

Optimal cut-off values for anthropometric measures of obesity in screening for cardiometabolic disorders in adults
por: Macek, Pawel, et al.
Publicado: (2020)

Assessment of Age-Induced Changes in Body Fat Percentage and BMI Aided by Bayesian Modelling: A Cross-Sectional Cohort Study in Middle-Aged and Older Adults
por: Macek, Pawel, et al.
Publicado: (2020)

Release of doxorubicin from its liposomal coating via high intensity ultrasound
por: Mikolajczyk, Agata, et al.
Publicado: (2019)

Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients?
por: Mertowska, Paulina, et al.
Publicado: (2023)

Seasonal influenza vaccination among cancer patients during the COVID-19 pandemic in Poland
por: Bartoszkiewicz, Mikolaj, et al.
Publicado: (2021)

Pegylated liposomal doxorubicin in ovarian cancer
por: Green, Andrew E, et al.
Publicado: (2006)

Pegylated liposomal doxorubicin in ovarian cancer
por: Strother, Robert, et al.
Publicado: (2009)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment—A Cardio-Oncology Study
por: Wilk, Michał, et al.
Publicado: (2021)

Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2016)

Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer
por: Grela-Wojewoda, Aleksandra, et al.
Publicado: (2022)

WHO recommendations on physical activity versus compliance rate within a specific urban population as assessed through IPAQ survey: a cross-sectional cohort study
por: Macek, Pawel, et al.
Publicado: (2019)

Age-Dependent Disparities in the Prevalence of Single and Clustering Cardiovascular Risk Factors: A Cross-Sectional Cohort Study in Middle-Aged and Older Adults
por: Macek, Pawel, et al.
Publicado: (2020)

Next-Generation Sequencing-Based Analysis of Clinical and Pathological Features of PIK3CA-Mutated Breast Cancer
por: Smok-Kalwat, Jolanta, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor Related Rheumatological Complications: Cooperation between Rheumatologists and Oncologists
por: Pacholczak-Madej, Renata, et al.
Publicado: (2023)

Sudden cardiac arrest in takotsubo cardiomyopathy – a case study
por: Sosnowska-Pasiarska, Barbara, et al.
Publicado: (2014)

Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2018)

Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Systematic Review
por: Püsküllüoğlu, Mirosława, et al.
Publicado: (2022)

Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model
por: Islam, Md. Rakibul, et al.
Publicado: (2022)

Pegylated liposomal doxorubicin in the management of ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2010)

A tale of the two PEGylated liposomal doxorubicins
por: Chou, Hunghsueh, et al.
Publicado: (2015)

Liposomal doxorubicin-induced palmoplantar erythrodysthesia syndrome
por: Yadav, Nidhi, et al.
Publicado: (2015)

Analytical ultracentrifugation for analysis of doxorubicin loaded liposomes
por: Mehn, Dora, et al.
Publicado: (2017)

Pharmacokinetics of a liposomal formulation of doxorubicin in rats
por: Liu, Zongyu, et al.
Publicado: (2017)

Recent Preclinical and Clinical Progress in Liposomal Doxorubicin
por: Aloss, Kenan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cf0m5p40c43413ajpk533jdi1p